2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, Angela Yee-Moon | - |
dc.contributor.author | Akizawa, Tadao | - |
dc.contributor.author | Bavanandan, Sunita | - |
dc.contributor.author | Hamano, Takayuki | - |
dc.contributor.author | Liew, Adrian | - |
dc.contributor.author | Lu, Kuo-Cheng | - |
dc.contributor.author | Lumlertgul, Dusit | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Zhao, Ming-Hui | - |
dc.contributor.author | Fung, Samuel Ka-Shun | - |
dc.contributor.author | Obi, Yoshitsugu | - |
dc.contributor.author | Sumida, Keiichi | - |
dc.contributor.author | Choong, Lina Hui Lin | - |
dc.contributor.author | Goh, Bak Leong | - |
dc.contributor.author | Hao, Chuan-Ming | - |
dc.contributor.author | Kwon, Young-Joo | - |
dc.contributor.author | Tarng, Der-Cherng | - |
dc.contributor.author | Zuo, Li | - |
dc.contributor.author | Wheeler, David C. | - |
dc.contributor.author | Tsukamoto, Yusuke | - |
dc.contributor.author | Fukagawa, Masafumi | - |
dc.date.accessioned | 2021-09-01T01:16:11Z | - |
dc.date.available | 2021-09-01T01:16:11Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 2468-0249 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/62010 | - |
dc.description.abstract | The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) 2009 provided recommendations on the detection, evaluation, and treatment of CKD-MBD in patients CKD who are and are not undergoing dialysis. Because of the accumulation of evidence since this initial publication, the CKD-MBD Guideline underwent a selective update in 2017. In April 2018, KDIGO convened a CKD-MBD Guideline Implementation Summit in Japan with the key objective to discuss various barriers to the uptake and implementation of the CKD-MBD Guideline in 8 Asian countries/regions. These countries/regions were comparable according to their high-to-middle economic ranking assigned by theWorld Bank. The discussion took into account the availability of CKD-MBD medication therapies and government health policies that may influence reimbursement and practice patterns in the region. Most importantly, Summit participants developed a framework of multifaceted strategies aimed at overcoming barriers to guideline implementation. The Summit attendees suggested a shared decision-making approach between clinicians and patients in CKD-MBD management, as well as individualized care based on the treatment risk-benefit ratio. The Summit participants also discussed how KDIGO, as a guideline development organization, may work in partnership with local and national nephrology societies to provide education and facilitate implementation of the guideline by clinicians. The conclusions drawn from this Summit in Asia may serve as an important guide for other regions to follow. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | HEMODIALYSIS-PATIENTS | - |
dc.subject | FRACTURE RISK | - |
dc.subject | CALCIUM | - |
dc.subject | METABOLISM | - |
dc.subject | MORTALITY | - |
dc.subject | DENSITY | - |
dc.subject | OSTEOPOROSIS | - |
dc.subject | INDIVIDUALS | - |
dc.subject | PHOSPHORUS | - |
dc.subject | MANAGEMENT | - |
dc.title | 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwon, Young-Joo | - |
dc.identifier.doi | 10.1016/j.ekir.2019.09.007 | - |
dc.identifier.wosid | 000494963400003 | - |
dc.identifier.bibliographicCitation | KIDNEY INTERNATIONAL REPORTS, v.4, no.11, pp.1523 - 1537 | - |
dc.relation.isPartOf | KIDNEY INTERNATIONAL REPORTS | - |
dc.citation.title | KIDNEY INTERNATIONAL REPORTS | - |
dc.citation.volume | 4 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1523 | - |
dc.citation.endPage | 1537 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | HEMODIALYSIS-PATIENTS | - |
dc.subject.keywordPlus | FRACTURE RISK | - |
dc.subject.keywordPlus | CALCIUM | - |
dc.subject.keywordPlus | METABOLISM | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | DENSITY | - |
dc.subject.keywordPlus | OSTEOPOROSIS | - |
dc.subject.keywordPlus | INDIVIDUALS | - |
dc.subject.keywordPlus | PHOSPHORUS | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | bone mineral density | - |
dc.subject.keywordAuthor | calcium | - |
dc.subject.keywordAuthor | CKD | - |
dc.subject.keywordAuthor | dialysis | - |
dc.subject.keywordAuthor | hyperparathyroidism | - |
dc.subject.keywordAuthor | hyperphosphatemia | - |
dc.subject.keywordAuthor | KDIGO CKD-MBD Guideline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.